Italy · research

Altheia Science

Altheia Science is transforming the life of patients with autoimmune diseases throught innovative and curative cell and gene therapies.

PrivateFor profit

researchMilan, Italy

Against its peers

Set against 32 research companies in Italy. The ring marks the typical peer.

Staff1-10The typical size for its peers
Founded2017The same year as the typical peer
Website traffic#8.8MBusier than the typical peer's site (#10.8M)

Across all 5.9M companies: larger than 0% of those with a size listed; older than 5% of those with a founding year; website ranked #8,822,289 in the world, about 461 visits a month.

About Altheia Science

What it does

BiotechnologyHealth CareTherapeutics

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$11M

raised in total, currency not stated across 1 round

Last raised Sept 2018, 8 years ago

Rounds
1
Latest round
Series a
Investors
11 leading

Key facts

Who started it and how it trades.

Founded by
Alessandra Biffi, Paolo Fiorina, Pierluigi Paracchi

Every detail we hold

Everything the source datasets list about Altheia Science, field by field. Contact details are held but never shown.

The company7 fields

Name
Altheia Science
Type
For profit
Status
Private
Founded
2017
Founders
Alessandra Biffi, Paolo Fiorina, Pierluigi Paracchi
Industry
research
Categories
Biotechnology, Health Care, Therapeutics

Where3 fields

City
Milan
Country
Italy
Markets
European Union (EU), Europe, Middle East, and Africa (EMEA)

Size and reach3 fields

Staff band
1-10
Web traffic rank
#8,822,289
Monthly web visits
461
Show 9 more fieldsShow fewer fields

Funding, as listed7 fields

Total
11,000,000 (currency not stated)
Rounds
1
Latest round
Series a
Latest round date
Sept 2018
Investors
1
Lead investors
1
Listing status
private

About this record2 fields

Sources
Crunchbase
Last imported
Sept 2026

Companies like Altheia Science

research in Italy.

Build a lead list

32 research companies in Italy, filtered by size, age and reach, ready to export with emails on Pro.

Open the list